Comparison 8. Vaginal PGE2 pessary versus vaginal PGE2 tablet.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Caesarean section	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	1.09 [0.74, 1.60]
2 Oxytocin augmentation	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	1.5 [0.81, 2.78]
3 Uterine hyperstimulation (FHR change not mentioned)	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	0.5 [0.05, 5.43]
4 Uterine rupture	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	0.33 [0.01, 8.09]
5 Apgar score < 7 at 5 minutes	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	0.8 [0.22, 2.89]
6 Neonatal intensive care unit admission	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	0.75 [0.17, 3.27]
7 Neonatal infection	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	1.0 [0.06, 15.77]
8 Postpartum haemorrhage	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	1.0 [0.14, 6.96]
9 Chorioamnionitis	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	1.0 [0.06, 15.77]
10 Endometritis	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	1.5 [0.26, 8.79]
11 Maternal intensive care unit admission (serious maternal complications)	1	200	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]